RecruitingPhase 3NCT05285917

Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa

Studying Sickle cell anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Brown University
Principal Investigator
Patrick T McGann, MD, MS
Rhode Island Hospital and Hasbro Children's Hospital
Intervention
Hydroxyurea(drug)
Enrollment
400 enrolled
Eligibility
12 years · All sexes
Timeline
2023 – 2027

Study locations (1)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI) · Novartis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05285917 on ClinicalTrials.gov

Other trials for Sickle cell anemia

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell anemia →

← Back to all trials